Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 1
2005 7
2006 1
2007 4
2008 7
2009 11
2010 25
2011 40
2012 40
2013 43
2014 48
2015 33
2016 56
2017 27
2018 18
2019 21
2020 10
Text availability
Article attribute
Article type
Publication date

Search Results

372 results
Results by year
Filters applied: . Clear all
Page 1
The therapeutic use of analgesics in patients with liver cirrhosis: a literature review and evidence-based recommendations.
Imani F, Motavaf M, Safari S, Alavian SM. Imani F, et al. Among authors: alavian sm. Hepat Mon. 2014 Oct 11;14(10):e23539. doi: 10.5812/hepatmon.23539. eCollection 2014 Oct. Hepat Mon. 2014. PMID: 25477978 Free PMC article. Review.
The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
Daneshi-Maskooni M, Keshavarz SA, Mansouri S, Qorbani M, Alavian SM, Badri-Fariman M, Jazayeri-Tehrani SA, Sotoudeh G. Daneshi-Maskooni M, et al. Among authors: alavian sm. Trials. 2017 Jun 7;18(1):260. doi: 10.1186/s13063-017-1979-3. Trials. 2017. PMID: 28592311 Free PMC article. Clinical Trial.
Art and viral hepatitis elimination programmes.
Nima M, Karimi-Sari H, Alavian SM. Nima M, et al. Among authors: alavian sm. J Virus Erad. 2018 Jan 1;4(1):59-60. J Virus Erad. 2018. PMID: 29568557 Free PMC article.
Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
Daneshi-Maskooni M, Keshavarz SA, Qorbani M, Mansouri S, Alavian SM, Badri-Fariman M, Jazayeri-Tehrani SA, Sotoudeh G. Daneshi-Maskooni M, et al. Among authors: alavian sm. BMC Complement Altern Med. 2019 Mar 12;19(1):59. doi: 10.1186/s12906-019-2465-0. BMC Complement Altern Med. 2019. PMID: 30871514 Free PMC article. Clinical Trial.
Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial.
Cheraghpour M, Imani H, Ommi S, Alavian SM, Karimi-Shahrbabak E, Hedayati M, Yari Z, Hekmatdoost A. Cheraghpour M, et al. Among authors: alavian sm. Phytother Res. 2019 Aug;33(8):2118-2125. doi: 10.1002/ptr.6406. Epub 2019 Jul 1. Phytother Res. 2019. PMID: 31264313 Clinical Trial.
Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population Level.
Karimzadeh H, Kiraithe MM, Oberhardt V, Salimi Alizei E, Bockmann J, Schulze Zur Wiesch J, Budeus B, Hoffmann D, Wedemeyer H, Cornberg M, Krawczyk A, Rashidi-Alavijeh J, Rodríguez-Frías F, Casillas R, Buti M, Smedile A, Alavian SM, Heinold A, Emmerich F, Panning M, Gostick E, Price DA, Timm J, Hofmann M, Raziorrouh B, Thimme R, Protzer U, Roggendorf M, Neumann-Haefelin C. Karimzadeh H, et al. Among authors: alavian sm. Gastroenterology. 2019 May;156(6):1820-1833. doi: 10.1053/j.gastro.2019.02.003. Epub 2019 Feb 12. Gastroenterology. 2019. PMID: 30768983 Free PMC article.
Effects of a Low-Calorie, Low-Carbohydrate Soy Containing Diet on Systemic Inflammation Among Patients with Nonalcoholic Fatty Liver Disease: A Parallel Randomized Clinical Trial.
Kani AH, Alavian SM, Esmaillzadeh A, Adibi P, Haghighatdoost F, Azadbakht L. Kani AH, et al. Among authors: alavian sm. Horm Metab Res. 2017 Sep;49(9):687-692. doi: 10.1055/s-0042-118707. Epub 2017 Jul 31. Horm Metab Res. 2017. PMID: 28759939 Clinical Trial.
Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol.
Jazayeri-Tehrani SA, Rezayat SM, Mansouri S, Qorbani M, Alavian SM, Daneshi-Maskooni M, Hosseinzadeh-Attar MJ. Jazayeri-Tehrani SA, et al. Among authors: alavian sm. BMJ Open. 2017 Jul 10;7(7):e016914. doi: 10.1136/bmjopen-2017-016914. BMJ Open. 2017. PMID: 28698350 Free PMC article. Clinical Trial.
The effect of hesperidin supplementation on metabolic profiles in patients with metabolic syndrome: a randomized, double-blind, placebo-controlled clinical trial.
Yari Z, Movahedian M, Imani H, Alavian SM, Hedayati M, Hekmatdoost A. Yari Z, et al. Among authors: alavian sm. Eur J Nutr. 2020 Sep;59(6):2569-2577. doi: 10.1007/s00394-019-02105-2. Epub 2019 Dec 16. Eur J Nutr. 2020. PMID: 31844967
Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic review.
Haghgoo SM, Sharafi H, Alavian SM. Haghgoo SM, et al. Among authors: alavian sm. Clin Chem Lab Med. 2019 Apr 24;57(5):577-610. doi: 10.1515/cclm-2018-0357. Clin Chem Lab Med. 2019. PMID: 30231008 Free article.
372 results
Jump to page
Feedback